Amgen, Sandoz Duel Over En Banc Bids In Biosimilars Fight
Amgen Inc. and Sandoz Inc. separately asked the full Federal Circuit on Tuesday to reject the other's challenge to a fractured panel decision on key elements of the Affordable Care Act's...To view the full article, register now.
Already a subscriber? Click here to view full article